Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study, Lancet Neurol, vol.16, issue.11, pp.877-97, 2015. ,
Global research priorities for infections that affect the nervous system, Nature, vol.527, issue.7578, pp.178-86, 2015. ,
Access to pathology and laboratory medicine services: a crucial gap, The Lancet, vol.391, pp.1927-1965, 2018. ,
Grand challenges in neuroinfectious diseases, Front Neurol, vol.8, p.480, 2017. ,
Epidemiology, outcomes and prognosis of central nervous system infections in Singapore, Preliminary results from The Singapore Neurologic Infections Programme, 2017. ,
A pragmatic cluster randomised controlled trial of a tailored intervention to improve the initial management of suspected encephalitis, PLoS ONE, vol.13, issue.12, p.202257, 2018. ,
Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study, Lancet Infect Dis, vol.18, issue.9, pp.992-1003, 2018. ,
Causality in acute encephalitis: defining aetiologies, Epidemiol Infect, vol.138, issue.6, pp.783-800, 2010. ,
Encephalitis diagnosis using metagenomics: application of next generation sequencing for undiagnosed cases, J Infect, 2018. ,
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study, Lancet Infect Dis, vol.10, issue.12, pp.835-879, 2010. ,
A tale of two approaches: how metagenomics and proteomics are shaping the future of encephalitis diagnostics, Curr Opin Neurol, vol.28, issue.3, pp.283-290, 2015. ,
Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis, N Engl J Med, vol.380, issue.24, pp.2327-2367, 2019. ,
Chapter 123 -Subacute sclerosing panencephalitis and chronic viral encephalitis, Handbook of Clinical Neurology, pp.1183-1192, 2013. ,
Astrovirus VA1/HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patients, Clinic Infect Dis Offic Publ Infect Dis Soc Am, vol.60, issue.6, pp.881-889, 2015. ,
Astrovirus MLB2, a new gastroenteric virus associated with meningitis and disseminated infection, Emerg Infect Dis, vol.22, issue.5, pp.846-53, 2016. ,
Astrovirus encephalitis in boy with X-linked agammaglobulinemia, Emerg Infect Dis, vol.16, issue.6, pp.918-943, 2010. ,
Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg Infect Dis, vol.17, issue.8, pp.1484-1491, 2011. ,
A new arenavirus in a cluster of fatal transplant-associated diseases, N Engl J Med, vol.358, issue.10, pp.991-999, 2008. ,
NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system, PLoS Negl Trop Dis, vol.12, issue.12, 2018. ,
Genome-wide host RNA signatures of infectious diseases: discovery and clinical translation, Immunology, vol.153, issue.2, pp.171-179, 2018. ,
The global dynamics of RNA stability orchestrates responses to cellular activation, BMC Biol, vol.8, issue.1, p.95, 2010. ,
Promises and pitfalls of untargeted metabolomics, J Inherit Metab Dis, vol.41, issue.3, pp.355-66, 2018. ,
Detection of the dengue non-structural 1 antigen in cerebral spinal fluid samples using a commercially available enzyme-linked immunosorbent assay, J Virol Methods, vol.177, issue.1, pp.128-159, 2011. ,
Clinical and laboratory diagnosis of dengue virus infection, J Infect Dis, vol.215, issue.suppl_2, pp.89-95, 2017. ,
Infections of the Central Nervous System, 2014. ,
Acute encephalitis in immunocompetent adults, The Lancet, vol.393, pp.702-718, 2019. ,
Proteins of the Cerebrospinal Fluid: Analysis & Interpretation in the Diagnosis and Treatment of Neurological Disease, 2005. ,
What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema, Scand J Clinic Lab Invest, vol.242, pp.6-14, 2010. ,
Use of MALDI-TOF mass spectrometry in the battle against bacterial infectious diseases: recent achievements and future perspectives, Expert Rev Proteomics, vol.14, issue.3, pp.253-67, 2017. ,
Mass spectrometry for translational proteomics: Progress and clinical implications, 2012. ,
Proteomic and Metabolomic Approaches to Biomarker Discovery, 2013. ,
Body fluid biomarkers for multiple sclerosis-the long road to clinical application, Nat Rev Neurol, vol.11, issue.10, pp.585-96, 2015. ,
Statistical design of quantitative mass spectrometry-based proteomic experiments, J Proteome Res, vol.8, issue.5, pp.2144-56, 2009. ,
Recommendations for biomarker identification and qualification in clinical proteomics, Sci Transl Med, vol.2, issue.46, pp.46-48, 2010. ,
Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders, Neurology, vol.83, issue.13, pp.1210-1226, 2014. ,
Biomarkers for neurology: guides and lines, Neurology, vol.83, issue.13, pp.1130-1131, 2014. ,
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis, Mult Scler, vol.19, issue.13, pp.1802-1811, 2013. ,
White paper by the society for CSF analysis and clinical neurochemistry: overcoming barriers in biomarker development and clinical translation, Alzheimers Res Ther, vol.10, issue.1, p.30, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01842202
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking, Neurology, vol.73, issue.22, pp.1914-1936, 2009. ,
Cerebrospinal fluid proteome of patients with acute Lyme disease, J Proteome Res, vol.11, issue.10, pp.4814-4836, 2012. ,
Identification of a novel biomarker candidate, a 4.8-kDa peptide fragment from a neurosecretory protein VGF precursor, by proteomic analysis of cerebrospinal fluid from children with acute encephalopathy using SELDI-TOF-MS, BMC Neurol, vol.11, issue.101, 2011. ,
Comparative proteomics of cerebrospinal fluid reveals a predictive model for differential diagnosis of pneumococcal, meningococcal, and enteroviral meningitis, and novel putative therapeutic targets, BMC Genom, vol.16, p.9, 2015. ,
Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease, PLoS ONE, vol.9, issue.4, p.93637, 2014. ,
Quantitative proteomics of cerebrospinal fluid in paediatric pneumococcal meningitis, Sci Rep, vol.7, p.11, 2017. ,
Elevated host lipid metabolism revealed by iTRAQ-based quantitative proteomic analysis of cerebrospinal fluid of tuberculous meningitis patients, Biochem Biophys Res Commun, vol.466, issue.4, pp.689-695, 2015. ,
Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children, Am J Tropic Med Hygiene, vol.97, issue.5, pp.209-219, 2017. ,
An iTRAQ approach to quantitative proteome analysis of cerebrospinal fluid from patients with tuberculous meningitis, Biosci Trends, vol.7, issue.4, pp.186-92, 2013. ,
Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome, PLoS ONE, vol.6, issue.2, p.17287, 2011. ,
Cerebrospinal fluid biomarkers of Japanese encephalitis, vol.4, p.334, 2015. ,
Increased acute immune response during the meningo-encephalitic stage of Trypanosoma brucei rhodesiense sleeping sickness compared to Trypanosoma brucei gambiense, Transl Proteom, vol.6, pp.1-9, 2015. ,
iTRAQ-based quantitative proteomic analysis of cerebrospinal fluid reveals NELL2 as a potential diagnostic biomarker of tuberculous meningitis, Int J Mol Med, vol.35, issue.5, pp.1323-1355, 2015. ,
Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics, Data Brief, vol.4, pp.400-405, 2015. ,
Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects, J Proteomics, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01936184
Expansion of the gene ontology knowledgebase and resources, Nucleic Acids Res, vol.45, issue.D1, pp.331-334, 2017. ,
The string database in 2017: quality-controlled protein-protein association networks, made broadly accessible, Nucleic Acids Res, vol.45, issue.D1, pp.362-365, 2017. ,
PRIDE: the proteomics identifications database, Proteomics, vol.5, issue.13, pp.3537-3582, 2005. ,
The human genome project, The Lancet, vol.334, issue.8678, pp.1535-1541, 1989. ,
Waste, leaks, and failures in the biomarker pipeline, Clin Chem, vol.63, issue.5, pp.963-72, 2017. ,
Adult CSF total protein upper reference limits should be age-partitioned and significantly higher than 0.45 g/L: a systematic review, J Neurol, 2019. ,
Needle lost in the haystack: multiple reaction monitoring fails to detect Treponema pallidum candidate protein biomarkers in plasma and urine samples from individuals with syphilis, vol.7, p.336, 2018. ,
Deep dive on the proteome of human cerebrospinal fluid: a valuable data resource for biomarker discovery and missing protein identification, J Proteome Res, vol.17, issue.12, pp.4113-4139, 2018. ,
Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation, J Neuroinflamm, vol.15, issue.1, p.20, 2018. ,
Commercial immunoassays in biomarkers studies: researchers beware, Clin Chem, vol.58, issue.10, pp.1387-1395, 2012. ,
Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support preclinical and clinical studies, J Pharm Biomed Anal, vol.55, issue.5, pp.869-77, 2011. ,